2m 2m 2m 2m 2m 2m 2m
Inogen (INGN)
NASDAQ
$6.16+$0.17 (+2.93%)
Price as of Jun 03, 2026 7:54 PM EDT- $175.7MMarket Cap
- -4.69%1-Year Change
- Medical DevicesIndustry
Inogen (INGN)
$6.16+$0.17 (+2.93%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 348.7M +3.86% | 335.7M +6.35% | 315.7M -16.32% | 377.2M +5.37% | |
Cost of Revenue | 194.4M +7.43% | 181.0M -4.23% | 189.0M -15.53% | 223.7M +23.24% | |
Gross Profit | 154.3M -0.31% | 154.7M +22.13% | 126.7M -17.48% | 153.5M -13.00% | |
Sales and Marketing Expense | 97.7M -5.22% | 103.1M -3.76% | 107.1M -11.32% | 120.8M +7.05% | |
Research and Development Expense | -19.4M -10.23% | -21.6M +3.69% | -20.8M -5.03% | -21.9M +32.38% | |
Depreciation and Amortization Expense | 20.7M -1.64% | 21.0M +15.71% | 18.2M -22.80% | 23.5M +8.72% | |
Total Operating Expenses | 184.5M -6.48% | 197.3M -16.45% | 236.1M -1.13% | 238.8M +42.77% | |
Operating Profit | -30.2M -28.95% | -42.5M -61.13% | -109.4M +28.32% | -85.2M -1,022.54% | |
Interest Income | 4.4M -15.51% | 5.2M -21.05% | 6.6M +131.72% | 2.8M +2,099.22% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 4.4M -15.51% | 5.2M -21.05% | 6.6M +131.72% | 2.8M +2,099.22% | |
Total Nonoperating Income and Expense | 6.8M +13.05% | 6.0M -14.23% | 7.0M +256.56% | 2.0M +439.93% | |
Income before Taxes | -23.4M -35.91% | -36.5M -64.36% | -102.3M +22.91% | -83.3M -1,061.64% | |
Income Taxes | -632,000 +7.48% | -588,000 -660.00% | 105,000 -79.17% | 504,000 -96.64% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -22.7M -36.62% | -35.9M -64.97% | -102.4M +22.30% | -83.8M +1,222.79% | |
Net Income from Continuing Operations Applicable to Common | -23.4M -35.91% | -36.5M -64.36% | -102.3M +22.91% | -83.3M -1,061.64% | |
Basic EPS and Net Income | -0.86 -43.42% | -1.52 -65.61% | -4.42 +20.44% | -3.67 +1,210.71% | |
Diluted EPS and Net Income | -0.86 -43.42% | -1.52 -65.61% | -4.42 +20.44% | -3.67 +1,210.71% | |
Basic Weighted Average Shares | 26.6M +12.46% | 23.7M +2.06% | 23.2M +1.42% | 22.9M +1.61% | |
Diluted Weighted Average Shares | 26.6M +12.46% | 23.7M +2.06% | 23.2M +1.42% | 22.9M +1.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 103.7M -8.85% | 113.8M -9.32% | 125.5M -32.90% | 187.0M -20.60% | |
Short-Term Investments | 15.8M +431.99% | 3.0M 0.00% | 3.0M -70.18% | 10.0M 0.00% | |
Cash and Cash Equivalents and Short-Term Investments | 119.6M +2.40% | 116.8M -9.10% | 128.5M -34.79% | 197.0M -19.76% | |
Total Current Assets | 198.3M +6.93% | 185.5M -10.44% | 207.1M -32.03% | 304.6M -7.46% | |
Accumulated Depreciation | 33.1M -26.01% | 44.7M -6.50% | 47.8M -7.71% | 51.8M +0.34% | |
Property and Plant and Equipment and Net | 36.4M -18.10% | 44.4M -11.76% | 50.3M +16.29% | 43.3M +11.16% | |
Total Long-Term Assets | 6.0M -25.73% | 8.1M +111.27% | 3.8M +56.44% | 2.4M -27.30% | |
Total Assets | 298.6M +0.82% | 296.2M -9.20% | 326.2M -19.47% | 405.0M -17.26% | |
Income Taxes Payable | 6.9M -2.23% | 7.1M -17.23% | 8.6M +11,321.33% | 75,000 -25.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 63.5M -17.15% | 76.7M +5.78% | 72.5M +10.94% | 65.3M +6.24% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 31.4M -13.31% | 36.2M -16.84% | 43.6M +44.47% | 30.2M -14.29% | |
Total Liabilities | 106.4M -13.02% | 122.3M +0.78% | 121.4M +12.77% | 107.6M -9.77% | |
Retained Earnings | -175.6M +14.88% | -152.8M +30.69% | -116.9M +706.54% | -14.5M -120.93% | |
Total Stockholders Equity | 192.2M +10.57% | 173.9M -15.11% | 204.8M -31.13% | 297.4M -19.67% | |
Total Shares Outstanding | 27.2M +13.93% | 23.9M +2.48% | 23.3M +1.67% | 22.9M +0.92% | |
Cash Flow | |||||
Cash from Operating Activities | -11.2M -289.65% | 5.9M +282.87% | -3.2M -91.38% | -37.5M -258.81% | |
Capital Expenditures | 2.5M -24.91% | 3.4M -35.61% | 5.2M +56.37% | 3.3M -39.13% | |
Cash from Investing Activities | -26.2M +87.54% | -14.0M -76.44% | -59.3M +445.32% | -10.9M -25.73% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 24.2M +9,025.28% | 265,000 -72.40% | 960,000 +152.63% | 380,000 -97.47% | |
Financials Ratio | |||||
Gross Margin | 44.24% -4.01% | 46.09% +14.84% | 40.14% -1.38% | 40.70% -17.44% | |
Operating Margin | -8.66% -31.59% | -12.66% -63.45% | -34.65% +53.36% | -22.60% -975.49% | |
Return on Assets | -7.65% -33.68% | -11.53% -58.84% | -28.02% +49.61% | -18.73% +1,306.74% | |
Return on Equity | -12.43% -34.44% | -18.95% -53.54% | -40.80% +62.58% | -25.10% +1,326.27% | |
Revenue Growth | 3.86% -39.19% | 6.35% +138.90% | -16.32% -403.78% | 5.37% -66.52% | |
Current Ratio | 3.12 +29.06% | 2.42 -15.33% | 2.86 -38.73% | 4.66 -12.89% | |
Cash Ratio | 1.63 +10.02% | 1.48 -14.27% | 1.73 -39.51% | 2.86 -25.26% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow